**Question:** Anti CD120 antibody is now the treatment of choice for -

**Core Concept:** CD120, also known as tumor necrosis factor-alpha (TNF-alpha), is a pro-inflammatory cytokine that plays a crucial role in the immune response. Anti-CD120 antibodies are a type of biologic therapy that can target and neutralize the effects of TNF-alpha, thereby reducing inflammation and immune system overactivity.

**Why the Correct Answer is Right:**

The correct answer, **C. Rheumatoid Arthritis**, is based on the understanding that TNF-alpha is a key player in the pathogenesis of rheumatoid arthritis (RA). Anti-CD120 antibodies target TNF-alpha, leading to reduced inflammation and joint damage in patients with RA.

**Why Each Wrong Option is Incorrect:**

A. **Multiple Sclerosis (MS)**: MS is an autoimmune disorder affecting the central nervous system. While TNF-alpha is involved in MS, anti-CD120 antibodies are not a suitable treatment for MS due to its effects on the immune system affecting the central nervous system directly.

B. **Systemic Lupus Erythematosus (SLE)**: Although TNF-alpha is involved in SLE, anti-CD120 antibodies are not a suitable treatment for SLE as it affects the whole body and may exacerbate the symptoms of SLE by neutralizing TNF-alpha's protective effects.

D. **Infectious Diseases**: While TNF-alpha is involved in various infectious diseases, anti-CD120 antibodies are not a suitable treatment due to their broad effects on the immune system, potentially worsening the infection or hindering the body's ability to fight off pathogens.

**Clinical Pearl:**

The correct use of anti-CD120 antibodies is crucial to prevent potential adverse effects on the immune system. In cases like rheumatoid arthritis, targeting TNF-alpha can effectively reduce inflammation and joint damage, while in other conditions, the broader effects on the immune system may outweigh the benefits. Understanding the specific disease and its pathophysiology is essential for appropriate treatment selection.